Scott Langille

Scott Langille

Geen lopende functies
69 jaar
Health Technology
Consumer Services
Utilities

Profiel

Scott M.
Langille
worked as Director-Corporate Finance at Biovail Corp.
Served as CFO, Director & Head-Investor Relations at Aralez Pharmaceuticals Canada, Inc. from 2011 to 2016.
Held the position of Finance Director at AltiMed Pharmaceuticals Co. and Biovail Pharmaceuticals Canada.
Worked as Chief Financial Officer at Sparta Capital Ltd., Sernova Biotherapeutics, Inc. from 2016 to 2018, Wayland Group Corp., ViRexx Medical Corp.
from 2006 to 2007, Cipher Pharmaceuticals, Inc. from 2020 to 2022, and Pure Global Cannabis, Inc. in 2020.
Held the role of Vice President at Biovail Pharmaceuticals LLC and Controller at Zimmer of Canada Ltd. Education includes undergraduate studies at Toronto Metropolitan University and an MBA from the University of Toronto.

Eerdere bekende functies van Scott Langille

BedrijvenFunctieEinde
CIPHER PHARMACEUTICALS INC. Financieel Directeur/CFO 15-08-2022
PURE GLOBAL CANNABIS INC. Financieel Directeur/CFO 01-05-2020
SERNOVA BIOTHERAPEUTICS INC Financieel Directeur/CFO 04-05-2018
TRIBUTE PHARMACEUTICALS CANADA INC Financieel Directeur/CFO 01-01-2016
Financieel Directeur/CFO 01-05-2007
Ervaring van Scott Langille in detail bekijken

Opleiding van Scott Langille

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

7

Eerstegraads connecties

14

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit14

Health Technology

Health Technology

Utilities

Health Technology

Process Industries

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

AltiMed Pharmaceuticals Co.

Zimmer of Canada Ltd.

Distribution Services

Health Technology

  1. Beurs
  2. Insiders
  3. Scott Langille